Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,696 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Neuroblastoma in adolescents: genetic and clinical characterisation.
Castel V, Villamón E, Cañete A, Navarro S, Ruiz A, Melero C, Herrero A, Yáñez Y, Noguera R. Castel V, et al. Among authors: ruiz a. Clin Transl Oncol. 2010 Jan;12(1):49-54. doi: 10.1007/s12094-010-0466-z. Clin Transl Oncol. 2010. PMID: 20080471
MYCN gain and MYCN amplification in a stage 4S neuroblastoma.
Noguera R, Cañete A, Pellín A, Ruiz A, Tasso M, Navarro S, Castel V, Llombart-Bosch A. Noguera R, et al. Among authors: ruiz a. Cancer Genet Cytogenet. 2003 Jan 15;140(2):157-61. doi: 10.1016/s0165-4608(02)00677-5. Cancer Genet Cytogenet. 2003. PMID: 12645655
Prognostic value of the International Neuroblastoma Pathology Classification in Neuroblastoma (Schwannian stroma-poor) and comparison with other prognostic factors: a study of 182 cases from the Spanish Neuroblastoma Registry.
Burgues O, Navarro S, Noguera R, Pellín A, Ruiz A, Castel V, Llombart-Bosch A. Burgues O, et al. Among authors: ruiz a. Virchows Arch. 2006 Oct;449(4):410-20. doi: 10.1007/s00428-006-0253-y. Epub 2006 Aug 29. Virchows Arch. 2006. PMID: 16941154
Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancer.
Martín M, Rodríguez-Lescure A, Ruiz A, Alba E, Calvo L, Ruiz-Borrego M, Munárriz B, Rodríguez CA, Crespo C, de Alava E, López García-Asenjo JA, Guitián MD, Almenar S, González-Palacios JF, Vera F, Palacios J, Ramos M, Gracia Marco JM, Lluch A, Alvarez I, Seguí MA, Mayordomo JI, Antón A, Baena JM, Plazaola A, Modolell A, Pelegrí A, Mel JR, Aranda E, Adrover E, Alvarez JV, García Puche JL, Sánchez-Rovira P, Gonzalez S, López-Vega JM; GEICAM 9906 Study Investigators. Martín M, et al. Among authors: ruiz borrego m, ruiz a. J Natl Cancer Inst. 2008 Jun 4;100(11):805-14. doi: 10.1093/jnci/djn151. Epub 2008 May 27. J Natl Cancer Inst. 2008. PMID: 18505968 Free article. Clinical Trial.
Efficacy and safety of neoadjuvant chemotherapy with concurrent liposomal-encapsulated doxorubicin, paclitaxel and trastuzumab for human epidermal growth factor receptor 2-positive breast cancer in clinical practice.
Gavilá J, Guerrero Á, Climent MÁ, Fernández A, Gozalbo F, Carrascosa M, Camps J, Guillem V, Ruiz A. Gavilá J, et al. Among authors: ruiz a. Int J Clin Oncol. 2015 Jun;20(3):480-9. doi: 10.1007/s10147-014-0727-x. Epub 2014 Jul 11. Int J Clin Oncol. 2015. PMID: 25011497
Frequency of breast cancer with hereditary risk features in Spain: Analysis from GEICAM "El Álamo III" retrospective study.
Márquez-Rodas I, Pollán M, Escudero MJ, Ruiz A, Martín M, Santaballa A, Martínez Del Prado P, Batista N, Andrés R, Antón A, Llombart A, Fernandez Aramburu A, Adrover E, González S, Seguí MA, Calvo L, Lizón J, Rodríguez Lescure Á, Ramón Y Cajal T, Llort G, Jara C, Carrasco E, López-Tarruella S. Márquez-Rodas I, et al. Among authors: ruiz a. PLoS One. 2017 Oct 6;12(10):e0184181. doi: 10.1371/journal.pone.0184181. eCollection 2017. PLoS One. 2017. PMID: 28985233 Free PMC article.
2,696 results